Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?

door Loris Riccardo Lopetuso, Maria Ernestina Giorgio, Angela Saviano, Franco Scaldaferri, Antonio Gasbarrini, Giovanni Cammarota
Gepubliceerd in 2019-01-01

Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases

door Emanuele Rinninella, Marco Cintoni, Pauline Raoul, Gianluca Ianiro, Lucrezia Laterza, Loris Riccardo Lopetuso, Francesca Romana Ponziani, Antonio Gasbarrini, Maria Cristina Mele
Gepubliceerd in 2020-07-01

Interleukin 1β Blockade Reduces Intestinal Inflammation in a Murine Model of Tumor Necrosis Factor–Independent Ulcerative ColitisSummary

door Marina Liso, Giulio Verna, Elisabetta Cavalcanti, Stefania De Santis, Raffaele Armentano, Angela Tafaro, Antonio Lippolis, Pietro Campiglia, Antonio Gasbarrini, Mauro Mastronardi, Theresa Torres Pizarro, Fabio Cominelli, Loris Riccardo Lopetuso, Marcello Chieppa
Gepubliceerd in 2022-01-01

Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study

door Alfredo Papa, Franco Scaldaferri, Marcello Covino, Antonio Tursi, Federica Furfaro, Giammarco Mocci, Loris Riccardo Lopetuso, Giovanni Maconi, Stefano Bibbò, Marcello Fiorani, Lucrezia Laterza, Irene Mignini, Daniele Napolitano, Laura Parisio, Marco Pizzoferrato, Giuseppe Privitera, Daniela Pugliese, Tommaso Schepis, Elisa Schiavoni, Carlo Romano Settanni, Lorenzo Maria Vetrone, Alessandro Armuzzi, Silvio Danese, Antonio Gasbarrini
Gepubliceerd in 2022-04-01